Kalofonos Isabel sold CRNX
January 5, 2026 · Form 4 insider transaction
Kalofonos Isabel sold 2,500 shares of Crinetics Pharmaceuticals Inc at $55.00 per share, a transaction worth $137.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,500
Price
$55.00
Total value
$137.5K
InsiderKalofonos Isabel
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJanuary 5, 2026
Filing dateJanuary 7, 2026
Shares owned after834
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 7, 2025.; The common stock was sold by the Reporting Person in an open market transaction on the transaction date, at a sale price of $55.00 per share.